Author(s): Kiyokawa S, Hirata Y, Nagaoka Y, Shibano M, Taniguchi M,
Abstract Share this page
Abstract New 2-aminobenzamide-type histone deacetylase (HDAC) inhibitors were synthesized. They feature a sulfur-containing bicyclic arylmethyl moiety-a surface recognition domain introduced to increase in cellular uptake-and a substituted tert-amino group which affects physicochemical properties such as aqueous solubility. Compound 22 with a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group reduced the volume of human colon cancer HCT116 xenografts in nude mice to T/C 67\% by oral administration at 45mg/kg, which was comparable to the rate (T/C 62\%) for a positive control, MS-275. Western blot analyses as well as cell cycle and TUNEL assays by flow cytometry suggested that the two compounds inhibited the growth of cancer cells via similar mechanisms.
This article was published in Bioorg Med Chem
and referenced in Journal of Bioengineering & Biomedical Science